Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bhavesh Poladia"'
Autor:
Anant Ramaswamy, Vikas Ostwal, Nikhil Pande, Atul Sharma, Shekar Patil, Ravi Thippeswamy, Nikhil Ghadyalpatil, Rakesh Roy, Harish Peshwe, Bhavesh Poladia, Deepan Rajamanickam, Bharat Rangarajan, P R Neelesh Reddy, Vimal Pandita, Ashis Mukherjee, Aniket Thoke, Abhijit Sarkar, C T Satish, H Shashidara, S D Banavali
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 22-26 (2019)
Background: Regorafenib is considered a standard of care as third-line therapy in metastatic colorectal cancers (mCRCs). Materials and Methods: The study was based on a computerized clinical data form sent to oncologists across the country for entry
Externí odkaz:
https://doaj.org/article/7e56f6cbb0db4d42bbd0cb160c123c88
Autor:
Deepti Mishra, Saravana Rajamanickam, Aruna Prabhu, Deepan Rajamanickam, Bhavesh Poladia, Karthick Rajamanickam, N. Kathiresan, C. Shuba
Publikováno v:
Indian Journal of Surgical Oncology. 13:108-109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf343fe91b6e90f5b1f9d9515084e69
https://doi.org/10.1007/s13193-022-01586-8
https://doi.org/10.1007/s13193-022-01586-8
Autor:
Vikas Ostwal, Atul Sharma, Ashis Mukherjee, Harish Peshwe, Nikhil Pande, Rakesh Roy, Ravi Thippeswamy, N. Ghadyalpatil, Anant Ramaswamy, P R Neelesh Reddy, Shekar Patil, Aniket Thoke, Abhijit Sarkar, Bharat Rangarajan, Bhavesh Poladia, HP Shashidara, Vimal Pandita, C T Satish, S D Banavali, Deepan Rajamanickam
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 22-26 (2019)
South Asian Journal of Cancer
South Asian Journal of Cancer
Background: Regorafenib is considered a standard of care as third-line therapy in metastatic colorectal cancers (mCRCs). Materials and Methods: The study was based on a computerized clinical data form sent to oncologists across the country for entry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd87b1429b9d9a41f7dfd31041c9c203
http://journal.sajc.org/article.asp?issn=2278-330X
http://journal.sajc.org/article.asp?issn=2278-330X
Autor:
Nirmal Vivek Raut, Anant Ramaswamy, Ram Abhinav Kannan, K. Gupta, K Deepan Rajamanickam, Gautam Goyal, Ashay Karpe, Bhavesh Poladia, Bharatsinha Baburao Bhosale, Vipul Doshi, Joydeep Ghosh, Vikas Talreja, Arun Chandrasekharan, Avinash Talele, Manu Prasad, Rushab Kothari, Trinanjan Basu, Ashish Kumar Singh, Alok Goel
Publikováno v:
Journal of Clinical Oncology. 39:e21201-e21201
e21201 Background: Osimertinib is one of the favoured treatment options in EGFR mutated NSCLC and was established as a treatment option in last 2-3 years. However the treatment pattern post-osimertinib failure is not established. Hence we conducted t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d2ee386fd40f7eeefe0a7c9ca4c458b
https://doi.org/10.1200/jco.2021.39.15_suppl.e21201
https://doi.org/10.1200/jco.2021.39.15_suppl.e21201
Autor:
Ashish Singh, Nirmal Vivek Raut, Avinash Talele, K. Gupta, Manu Prasad, Vikas Talreja, Ashay Karpe, Bhavesh Poladia, Arun Chandrasekharan, Bharat Bhosale, Joydeep Ghosh, Gautam Goyal, Rushabh Kothari, Sameer Shrirangwar
Publikováno v:
Journal of Clinical Oncology. 39:e14012-e14012
e14012 Background: Leptomeningeal carcinomatosis (LCM) is a rare event and has a dismal prognosis. Limited data is available from India on LCM. Hence we did this country wise audit of LCM. Methods: This was a retrospective, multicentric audit of adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2d866af1da889cf6507f024fa4cee60
https://doi.org/10.1200/jco.2021.39.15_suppl.e14012
https://doi.org/10.1200/jco.2021.39.15_suppl.e14012
Autor:
Vipul Doshi, Subhadeep Bose, Vikas Ostwal, Shailesh V. Shrikhande, Bhawna Sirohi, Arvind Sahu, Bhavesh Poladia, Prabhat Bhargava, Anant Ramaswamy, Rohit Dusane, Chaitali Nashikkar
Publikováno v:
Indian Journal of Cancer. 55:88
Introduction: Docetaxel/oxaliplatin/capecitabine (TEX) is a commonly used combination chemotherapeutic regimen in advanced gastric cancer (AGC). Application strategies in routine clinical practice are reported in this study. Materials and Methods: Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60c222c1bde48bb2953b40f903f6e81
https://doi.org/10.4103/ijc.ijc_353_17
https://doi.org/10.4103/ijc.ijc_353_17
Autor:
V Muddu, Vanita Noronha, Shashikant Juvekar, Amit Joshi, Bhavesh Poladia, Bharat Chauhan, Devendra Chaukar, Anil K. D'Cruz, Pankaj Chatturvedi, Gouri Pantvaidya, Kumar Prabhash, Vijay Patil
Publikováno v:
Chemotherapy Research and Practice
Background. The standard initial management of patients with locally advanced pharyngolaryngeal presenting with stridor is tracheostomy. Tracheostomy has been shown to negatively impact cancer-related outcomes. Methods. Retrospective analysis of pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31a0491359b94d058d2df66e6eba4be
http://europepmc.org/articles/PMC3424664
http://europepmc.org/articles/PMC3424664
Autor:
Bharatsinha Baburao Bhosale, S Juvekar, Vijay Patil, Pankaj Chaturvedi, Anil K. D'Cruz, Amit Joshi, Kumar Prabhash, Bhavesh Poladia, Devendra Chaukar, P. S. Pai, Sushmita Rath, Vanita Noronha
Publikováno v:
Journal of Clinical Oncology. 31:6085-6085
6085 Background: A variety of regimens have been used for induction chemotherapy in locally advanced head & neck cancers. Cisplatin & 5 FU drug combination is inferior to the combination of taxane & these 2 drugs. However, often in clinical practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bed49590c2aa1ffb6bdbd15b52c175e7
https://doi.org/10.1200/jco.2013.31.15_suppl.6085
https://doi.org/10.1200/jco.2013.31.15_suppl.6085
Autor:
Snehal Punatar, Vanita Noronha, Anil K. D'Cruz, Sushmita Rath, Arvind Sahu, Amit Joshi, Bhavesh Poladia, Vijay Patil, Bharatsinha Baburao Bhosale, S Juvekar, Kumar Prabhash, Pankaj Chaturvedi
Publikováno v:
Journal of Clinical Oncology. 31:e12520-e12520
e12520 Background: The use of neoadjuvant chemotherapy(NACT) in head & neck cancers is not well defined. Very few publications on this topic deal with the epidemiology ,clinical & biochemical profile. These factors have an important say in deciding t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43b3960c1d376638efe44e34a7397766
https://doi.org/10.1200/jco.2013.31.15_suppl.e12520
https://doi.org/10.1200/jco.2013.31.15_suppl.e12520